Marijuana gummies carry real cardiovascular risks, and the fact that you are eating them rather than smoking them does not make your heart safe. A 2025 study in JAMA Cardiology found that chronic THC-edible users showed impaired blood vessel function at levels comparable to tobacco smokers, suggesting the problem is not limited to inhaled smoke. THC itself, regardless of how it enters the body, raises heart rate, shifts the autonomic nervous system toward a stress-like state, and can trigger dangerous heart rhythms in vulnerable people. The picture is more complicated than a simple “yes, they’re bad” because some cannabinoid pathways appear protective in lab settings, but the weight of current clinical evidence tilts toward caution.
What THC Does to Your Heart Right After You Take It
The most consistent short-term cardiovascular effect of THC is a faster heartbeat. A 2024 systematic review covering multiple routes of administration found that tachycardia was the most common cardiovascular effect and appeared regardless of whether cannabis was smoked, vaped, or eaten.1PubMed. Cardiovascular and Respiratory Effects of Cannabis Use by Route of Administration: A Systematic Review With gummies, the onset is slower than with smoking because THC has to pass through the digestive system and liver before reaching the bloodstream. That delayed onset means the heart-rate spike may not hit for an hour or more, but it still happens.
A placebo-controlled trial measuring the autonomic effects of oral THC found that it dose-dependently increased heart rate, reduced a marker of parasympathetic (calming) nervous system activity, and increased self-reported anxiety.2PubMed Central. Acute effects of oral delta-9-tetrahydrocannabinol (THC) on autonomic cardiac activity and their relation to subjective and anxiogenic effects In practical terms, THC shifts your nervous system toward fight-or-flight mode. For a young, healthy person, a temporary rise in heart rate from a low-dose gummy is unlikely to cause harm on its own. But for someone with an existing heart condition, high blood pressure, or a vulnerability to abnormal rhythms, that shift matters.
Edibles Still Damage Blood Vessels
One of the most important recent findings comes from a 2025 JAMA Cardiology study that directly compared chronic marijuana smokers, chronic THC-edible users, and nonusers. The researchers measured flow-mediated dilation (FMD), which reflects how well your arteries can relax and expand when they need to. Healthy arteries dilate easily; stiff, damaged arteries do not. Nonusers had an average FMD of about 10.4%. Marijuana smokers came in around 6.0%, and THC-edible users were even lower at roughly 4.6%.3JAMA Cardiology. Association of Endothelial Dysfunction With Chronic Marijuana Smoking and THC-Edible Use
That finding challenges the assumption many people hold: that gummies avoid the cardiovascular damage of smoking because there is no combustion, no tar, no carbon monoxide. The study found that while the mechanisms appeared to differ between smokers and edible users, the end result was similar levels of endothelial dysfunction. In smokers, serum reduced nitric oxide release from blood vessel cells in the lab, suggesting a direct toxic effect on the cells that line arteries. In edible users, that particular mechanism did not show up, yet the blood vessels were still impaired. The researchers concluded that THC ingestion and marijuana smoking both harm blood vessel function, just through distinct pathways.3JAMA Cardiology. Association of Endothelial Dysfunction With Chronic Marijuana Smoking and THC-Edible Use
Separately, lab work using human stem cell-derived blood vessel cells has shown that THC triggers inflammation and oxidative stress in endothelial tissue through a well-known inflammatory signaling pathway. In mice, this led to increased atherosclerotic plaque, the fatty buildup in arteries that causes heart attacks and strokes.4PubMed Central. Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation These are animal and cell studies, so direct human translation is uncertain, but they provide a biological explanation for why chronic THC exposure could accelerate artery disease regardless of whether you smoked or ate it.
Heart Rhythm Risks
Irregular heart rhythms are among the more alarming cardiovascular effects linked to cannabis, and gummies are not exempt. A comprehensive 2025 review found a significant association between cannabis use and various arrhythmias, with atrial fibrillation being the most commonly reported. Case reports have also linked cannabis use to ventricular tachycardia and ventricular fibrillation, particularly in people with underlying heart abnormalities.5PubMed Central. Arrhythmias and cannabis use: A comprehensive overview
One particularly striking case involved a 66-year-old woman who presented with syncope and was found to have a dangerously prolonged QT interval on her heart monitor, along with polymorphic ventricular tachycardia. An extensive cardiac workup found no structural cause. After she stopped using cannabinoids, her QT interval returned to normal.6PubMed Central. What We May not Know: Torsades de Pointes Induced by Cannabinoid Use Case reports are not proof that gummies caused the problem, but they illustrate the kind of scenario that concerns cardiologists. QT prolongation can lead to a fatal rhythm if not caught.
The mechanism behind these rhythm disturbances likely involves the endocannabinoid system’s deep involvement in cardiac electrical activity. Endocannabinoids naturally interact with CB1 and CB2 receptors, as well as other receptor types, throughout the cardiovascular system.7PubMed Central. Endocannabinoids and the heart When you flood that system with external THC from a gummy, you are overriding finely tuned signaling that normally helps regulate heart rhythm and blood vessel tone.
Stress Cardiomyopathy and Heart Attack
Takotsubo cardiomyopathy, sometimes called broken-heart syndrome, is a temporary but serious condition where the heart muscle suddenly weakens, usually in response to intense emotional or physical stress. A large database analysis of over 71 million hospital records identified marijuana use as an independent predictor of this condition, roughly doubling the odds after adjusting for other known risk factors.8PubMed Central. Marijuana Use and Stress Cardiomyopathy in the Young A separate review explored the neurological link, pointing to the amygdala as the common thread: both cannabis use and emotional stress cause hyperactivity in this brain region, which in turn can trigger the cascade of stress hormones that overwhelms the heart.9PubMed. Cannabis Use as a Risk Factor for Takotsubo (Stress) Cardiomyopathy: Exploring the Evidence from Brain-Heart Link
As for heart attacks, a 2024 systematic review examined how the method of cannabis use relates to myocardial infarction risk. Smoking cannabis had a statistically significant association with a history of heart attack, with an adjusted odds ratio of about 2.0. For edibles, the odds ratio was actually higher at about 2.36, but the result was not statistically significant because far fewer people in the study used edibles, leaving insufficient statistical power to draw firm conclusions.10PubMed Central. Cannabis Use Variations and Myocardial Infarction: A Systematic Review In other words, the data does not clear edibles of heart attack risk; there simply has not been enough research focused specifically on gummy and edible users to say definitively one way or the other. The researchers noted that small sample sizes for non-smoking routes likely explain the lack of statistical significance rather than a genuine absence of risk.
Drug Interactions That Could Affect Your Heart
If you take heart medications, gummies introduce a layer of risk that has nothing to do with THC’s direct effects on your cardiovascular system. Both THC and CBD are potent inhibitors of liver enzymes that break down many common drugs. Lab research using human liver tissue predicted that oral CBD at high doses could dramatically increase blood levels of drugs processed by the CYP3A enzyme family, with predicted increases of nearly 15-fold for some drugs, and could raise levels of CYP2C9-processed drugs by roughly 10-fold.11PubMed Central. Comprehensive Predictions of Cytochrome P450 (P450)-Mediated In Vivo Cannabinoid-Drug Interactions Based on Reversible and Time-Dependent P450 Inhibition in Human Liver Microsomes Oral THC also showed strong inhibition of CYP2C9 metabolism.12PubMed. Cannabinoid Interactions with Cytochrome P450 Drug Metabolism: a Full-Spectrum Characterization
Why does this matter for your heart? The blood thinner warfarin is processed by CYP2C9. If a gummy containing THC or CBD slows down the enzyme that clears warfarin from your body, warfarin levels can climb, raising bleeding risk. The same logic applies to certain beta-blockers, calcium channel blockers, and anti-arrhythmic drugs metabolized by CYP3A or CYP2C9. These are not theoretical concerns; the predicted interaction magnitudes from lab studies are large enough that researchers have called for formal drug interaction trials. If you take any prescription medication for a heart condition, the safest approach is to discuss cannabis edibles with your prescriber before using them.
Does CBD in Gummies Protect the Heart Rate?
Many cannabis gummies are marketed with specific CBD-to-THC ratios, and there is a widespread belief that CBD counteracts THC’s cardiovascular effects. A randomized, double-blind crossover trial tested this directly, giving participants cannabis with four different CBD-to-THC ratios and measuring cardiovascular responses. THC caused a large, significant increase in heart rate compared to baseline. Adding CBD at various ratios did not reduce that heart-rate spike; there were no significant differences in peak heart rate between the different CBD-to-THC ratio conditions.13Neuropsychopharmacology. Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios Blood pressure also showed no meaningful variation between conditions. This does not mean CBD is completely inert on the cardiovascular system, but it does undermine the marketing claim that CBD-rich gummies are “heart-safe” because of the CBD content.
The Platelet Puzzle
One area where the cardiovascular picture gets genuinely complicated is blood clotting. Platelets are the tiny cell fragments that stick together to form clots, and cannabinoids appear to make them less sticky. In vitro, the endocannabinoid anandamide inhibited platelet aggregation across multiple activating pathways. Human volunteers who consumed cannabis showed reduced platelet clumping in blood samples taken afterward.14PLoS ONE. Endocannabinoids Control Platelet Activation and Limit Aggregate Formation under Flow A study in nonhuman primates given daily THC edibles confirmed this: both female and male animals showed reduced platelet adhesion, aggregation, and granule secretion.15PubMed Central. Chronic edible dosing of Δ9-tetrahydrocannabinol (THC) in nonhuman primates reduces systemic platelet activity and function CBD and another cannabinoid called CBG also reduced platelet aggregation and thrombus formation under flow conditions in lab experiments.16University of Reading. The effects of phytocannabinoids cannabidiol and cannabigerol on platelet modulation, thrombus formation and inflammatory responses
At first glance, reduced clotting sounds like a good thing for heart health, since most heart attacks involve a clot blocking a coronary artery. But the reality is more nuanced. Reduced platelet function also means increased bleeding risk, which becomes dangerous if you are already on blood thinners or if you have a condition that predisposes you to bleeding. And anti-clotting effects in a lab dish or in monkeys do not automatically translate into fewer heart attacks in humans. No clinical trial has shown that eating THC gummies prevents cardiovascular events. The platelet findings are intriguing basic science, but they are a long way from being a reason to use gummies for heart health.
Delta-8 THC Gummies
Delta-8 THC gummies occupy a peculiar regulatory gray area in many U.S. states and are widely sold as a “milder” alternative to delta-9 THC. A crossover trial comparing equal oral doses of delta-8 and delta-9 THC in healthy adults found that delta-8 produced significantly smaller increases in heart rate along with lower subjective drug effects and less cognitive impairment.17PubMed. A within-subject cross-over trial comparing the acute effects of oral delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in healthy adults That suggests a somewhat gentler acute cardiovascular profile.
However, “milder” does not mean “safe.” A case report documented a reversible Brugada electrocardiogram pattern in a person after recreational delta-8 THC use.18PubMed Central. Brugada Electrocardiogram Pattern Induced by Recreational Delta-8-Tetrahydrocannabinol (THC): A Case Report Brugada pattern is a specific electrical abnormality associated with sudden cardiac death, though it can be transient and benign in some individuals. The broader concern with delta-8 gummies is that they are largely unregulated. Manufacturing quality varies enormously, contaminants are possible, and dosing consistency is unreliable. A product that claims to be lower risk on the THC side may introduce other cardiovascular risks through poor production standards.
Emergency Visits After Edibles
A retrospective analysis of emergency department visits attributed to acute cannabinoid use found a pattern that speaks to a unique hazard of edibles. Of 303 visits deemed highly likely to be cannabinoid-related, about 80% involved oral use and roughly 20% involved inhalation. While none of the inhaled-cannabis patients required hospital admission, about 6% of the oral-cannabis patients did. Additionally, roughly 27% of the oral group reported unintentional use, including hotel housekeepers who ate food products left behind by guests, compared to about 7% of the inhaled group.19PubMed Central. Emergency Department Patients Presenting after Oral versus Inhaled Cannabinoid use: A Retrospective Analysis – Section: Results
Edibles, including gummies, create a specific overdose dynamic. Because the effect is delayed, people often take a second dose before the first one kicks in. The resulting THC load can be much higher than intended, producing extreme tachycardia, anxiety that mimics a heart attack, and occasionally genuine cardiovascular events. Unintentional consumption is another risk that barely exists with smoked cannabis: a gummy looks and tastes like candy, and there is no warning before the effects begin.
Cerebrovascular Effects
The cardiovascular conversation around gummies tends to focus on the heart itself, but blood vessel damage can also affect the brain. A case report documented recurrent watershed strokes in a chronic daily marijuana user, with imaging showing constriction of cerebral arteries. When the patient was treated and the vasoconstriction resolved on follow-up imaging, the clinical picture strongly matched reversible cerebral vasoconstriction syndrome (RCVS).20PubMed Central. Marijuana-related Reversible Cerebral Vasoconstriction Syndrome RCVS involves sudden narrowing of brain arteries that can cause thunderclap headaches and, in severe cases, stroke. While this report involved a chronic user rather than specifically an edible user, the underlying mechanism involves THC’s effects on blood vessels, which occur regardless of how the THC is consumed.
Cannabinoid Receptors and the Cardioprotective Angle
It would be dishonest to present the cannabinoid-heart relationship as purely harmful, because basic science tells a more complex story. The heart has its own endocannabinoid system, and activating the CB2 receptor in particular appears to be protective in animal models of heart damage. In one study, activating CB2 receptors before experimentally induced ischemia-reperfusion injury in mice reduced the area of heart tissue death by roughly half, an effect that was blocked when a CB2-specific antagonist was given.21PubMed. Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN A more recent rat study confirmed that a different CB2 agonist reduced oxidative stress and infarct size after similar heart injury, working through a specific antioxidant signaling pathway.22PubMed Central. Cannabinoid Receptor-2 agonist AM1241 Attenuates Myocardial Ischemia-Reperfusion-Induced Oxidative Stress in Rats via Nrf2/HO-1 Pathway
These findings are genuinely promising for future drug development. But they involve targeted CB2 receptor agonists administered in controlled doses in a laboratory, not consumer THC gummies. THC activates both CB1 and CB2 receptors, and much of its harmful cardiovascular action appears to flow through CB1 activation, which promotes inflammation, raises heart rate, and shifts the nervous system toward sympathetic dominance. Eating a gummy delivers a blunt, whole-system cannabinoid load that activates protective and harmful pathways simultaneously. The net effect in humans, based on the clinical and epidemiological evidence available, leans toward risk rather than protection. The CB2 research points toward a future where specific cannabinoid-based heart drugs could exist, but that future does not describe the gummy you bought at a dispensary.